Miro-mediated mitochondrial transport: A new dimension for disease-related abnormal cell metabolism?

Biochem Biophys Res Commun. 2024 Feb 27;705:149737. doi: 10.1016/j.bbrc.2024.149737. Online ahead of print.ABSTRACTMitochondria are versatile and highly dynamic organelles found in eukaryotic cells that play important roles in a variety of cellular processes. The importance of mitochondrial transport in cell metabolism, including variations in mitochondrial distribution within cells and intercellular transfer, has grown in recent years. Several studies have demonstrated that abnormal mitochondrial transport represents an early pathogenic alteration in a variety of illnesses, emphasizing its significance in disease development and progression. Mitochondrial Rho GTPase (Miro) is a protein found on the outer mitochondrial membrane that is required for cytoskeleton-dependent mitochondrial transport, mitochondrial dynamics (fusion and fission), and mitochondrial Ca2+ homeostasis. Miro, as a critical regulator of mitochondrial transport, has yet to be thoroughly investigated in illness. This review focuses on recent developments in recognizing Miro as a crucial molecule in controlling mitochondrial transport and investigates its roles in diverse illnesses. It also intends to shed light on the possibilities of targeting Miro as a therapeutic method for a variety of diseases.PMID:38430606 | DOI:10.1016/j.bbrc.2024.149737
Source: Biochemical and Biophysical Research communications - Category: Biochemistry Authors: Source Type: research